However	O
,	O
three	O
puzzling	O
observations	O
were	O
difficult	O
to	O
reconcile	O
with	O
this	O
hypothesis	O
and	O
suggested	O
synaptotagmin	O
also	O
functions	O
upstream	O
of	O
Ca2+	O
triggering.For	O
Syt1	O
titration	O
experiments	O
in	O
presence	O
of	O
complexin-1	O
,	O
HEK293T	O
cells	O
were	O
cotransfected	O
with	O
pCMV5	O
syntaxin-1a	O
,	O
pCMV5	O
SNAP-25a	O
,	O
pCMV5	O
synaptobrevin-2	O
,	O
pCMV5	O
complexin-1	O
1:1:1:3	O
,	O
and	O
an	O
increasing	O
amount	O
of	O
pCMV5	O
Syt1	O
0	O
to	O
4-fold	O
.	O
A	O
The	O
top	O
25	O
novel	O
candidate	O
genes	O
not	O
in	O
the	O
exemplar	O
distribution	O
were	O
screened	O
for	O
physical	O
interactions	O
with	O
the	O
listed	O
subset	O
of	O
clock	O
factors.Genes	O
regulating	O
signalling	O
downstream	O
from	O
cytokine	O
receptors	O
were	O
also	O
strongly	O
up-regulated	O
:	O
the	O
Nuclear	O
factor	O
of	O
kappa	O
light	O
chain	O
gene	O
enhancer	O
in	O
B-cells	O
NFκB	O
signaling	O
pathway	O
,	O
Nfkb1	PROT
,	O
Nfkb2	PROT
,	O
Nfkb	PROT
inhibitor	O
Nfkbi	PROT
beta	O
,	O
Nfkbi	PROT
alpha	O
,	O
Nfkbi	PROT
epsilon	O
and	O
Nfkbi	PROT
zeta	O
and	O
,	O
the	O
JAKSTAT	O
pathway	O
Signal	O
transducer	O
and	O
activator	O
of	O
transcription	O
1	O
Stat1	O
,	O
Stat2	PROT
and	O
Stat3	O
.	O
When	O
fused	O
with	O
the	O
VP16	PROT
activation	O
domain	O
,	O
Cystathionine	PROT
Beta	PROT
Synthase	O
CBS	O
and	O
Interferon-induced	O
Transmembrane	O
Protein	O
1	O
IFITM1	O
demonstrated	O
binding	O
with	O
a	O
>	O
5-fold	O
activation	O
of	O
the	O
Gal4	PROT
UAS	O
reporter	O
over	O
control.A	O
&	O
B.	O
HEK293T	O
cells	O
were	O
cotransfected	O
with	O
plasmid-expressing	O
syntaxin-1a	O
Synt-1	O
,	O
SNAP-25	O
,	O
synaptobrevin-2	O
Syb-2	O
,	O
and	O
complexin-1	O
Cpx1	O
in	O
a	O
constant	O
1:1:1:3	O
ratio	O
,	O
together	O
with	O
an	O
increasing	O
amount	O
of	O
Syt1	O
expression	O
plasmid	O
0	O
to	O
4-fold	O
and	O
a	O
decreasing	O
amount	O
of	O
emerald	O
expression	O
plasmid	O
GFP	O
;	O
4	O
to	O
0-fold	O
to	O
balance	O
the	O
total	O
DNA	O
amount	O
.	O
The	O
50	O
structured	O
topics	O
can	O
be	O
expressed	O
within	O
the	O
biomedical	O
entity	O
tagged	O
,	O
for	O
example	O
,	O
topic110	O
can	O
be	O
expressed	O
as	O
following	O
:	O
Therefore	O
,	O
Interferon-beta	O
and	O
Multiple	O
Sclerosis	O
become	O
the	O
main	O
elements	O
in	O
the	O
query	O
space.Vacuum	O
infiltration	O
has	O
also	O
been	O
used	O
to	O
express	O
an	O
active	O
human	O
beta-interferon	O
in	O
lettuce	O
and	O
to	O
transform	O
lentil	O
cotyledonary	O
nodes	O
and	O
wheat	O
inflorescence	O
tissues	O
14	O
,31	O
,32	O
.	O
Ablation	O
of	O
complexin	O
also	O
increased	O
spontaneous	O
mini	O
release	O
at	O
least	O
in	O
some	O
preparations	O
,	O
suggesting	O
a	O
common	O
mode	O
of	O
action	O
of	O
Syt1	O
or	O
Syt2	O
with	O
complexin	O
in	O
clamping	O
mini	O
release	O
3	O
.	O
Second	O
,	O
blocking	O
Syt1	O
or	O
Syt2	O
function	O
but	O
not	O
Syt7	O
function	O
caused	O
an	O
increase	O
in	O
spontaneous	O
“	O
mini	O
”	O
release	O
in	O
a	O
manner	O
that	O
suggested	O
a	O
role	O
of	O
Syt1	O
and	O
Syt2	O
in	O
clamping	O
minis	O
upstream	O
of	O
Ca2+	O
triggering	O
24	O
,26	O
,39	O
,48–50.GM129CHRONO	O
was	O
screened	O
in	O
the	O
same	O
way	O
and	O
bound	O
BMAL1	PROT
and	O
PER2	O
as	O
shown	O
in	O
Figure	O
3	O
.	O
For	O
Syt1	O
titration	O
experiments	O
in	O
presence	O
of	O
complexin-1	O
,	O
HEK293T	O
cells	O
were	O
cotransfected	O
with	O
pCMV5	O
syntaxin-1a	O
,	O
pCMV5	O
SNAP-25a	O
,	O
pCMV5	O
synaptobrevin-2	O
,	O
pCMV5	O
complexin-1	O
1:1:1:3	O
,	O
and	O
an	O
increasing	O
amount	O
of	O
pCMV5	O
Syt1	O
0	O
to	O
4-fold	O
.	O
The	O
data	O
used	O
to	O
make	O
this	O
figure	O
can	O
be	O
found	O
in	O
S1	O
Data.Total	O
DNA	O
was	O
kept	O
constant	O
by	O
balancing	O
the	O
Syt1	O
plasmid	O
with	O
pCMV5	O
emerald	O
4	O
to	O
0-fold	O
.	O
HEK293T	O
cells	O
were	O
cotransfected	O
with	O
plasmid	O
expressing	O
Synt-1	O
,	O
SNAP-25	O
,	O
Syb-2	O
,	O
and	O
complexin-1	O
in	O
a	O
1:1:1:3	O
ratio	O
,	O
together	O
with	O
an	O
increasing	O
amount	O
of	O
Syt1	O
expression	O
plasmid	O
0	O
to	O
4-fold	O
,	O
and	O
decreasing	O
amount	O
of	O
emerald	O
expression	O
plasmid	O
GFP	O
;	O
4	O
to	O
0-fold.Second	O
,	O
blocking	O
Syt1	O
or	O
Syt2	O
function	O
but	O
not	O
Syt7	O
function	O
caused	O
an	O
increase	O
in	O
spontaneous	O
“	O
mini	O
”	O
release	O
in	O
a	O
manner	O
that	O
suggested	O
a	O
role	O
of	O
Syt1	O
and	O
Syt2	O
in	O
clamping	O
minis	O
upstream	O
of	O
Ca2+	O
triggering	O
24	O
,26	O
,39	O
,48–50	O
.	O
Gene	O
and	O
protein	O
names	O
follow	O
few	O
,	O
if	O
any	O
,	O
true	O
naming	O
conventions	O
and	O
are	O
subject	O
to	O
great	O
variation	O
in	O
different	O
occurrences	O
of	O
the	O
same	O
name.To	O
reduce	O
the	O
dismatch	O
between	O
query	O
and	O
document	O
,	O
internal	O
resource	O
for	O
the	O
query	O
expansion	O
purpose	O
is	O
introduced	O
See	O
Section	O
2.2	O
.	O
First	O
,	O
loss-of-function	O
of	O
complexin	O
,	O
which	O
is	O
an	O
essential	O
cofactor	O
of	O
all	O
synaptotagmins	O
in	O
Ca2+	O
triggering	O
of	O
fusion	O
40–44	O
,	O
decreases	O
the	O
size	O
of	O
the	O
RRP	O
approximately	O
2–3-fold	O
45–47.When	O
fused	O
with	O
the	O
VP16	PROT
activation	O
domain	O
,	O
Cystathionine	PROT
Beta	PROT
Synthase	O
CBS	O
and	O
Interferon-induced	O
Transmembrane	O
Protein	O
1	O
IFITM1	O
demonstrated	O
binding	O
with	O
a	O
>	O
5-fold	O
activation	O
of	O
the	O
Gal4	PROT
UAS	O
reporter	O
over	O
control	O
.	O
Using	O
interferon-beta	O
,	O
multiple	O
sclerosis	O
and	O
their	O
corresponding	O
synonyms	O
as	O
a	O
query	O
would	O
retrieve	O
articles	O
that	O
used	O
interferon-beta	O
as	O
a	O
treatment	O
,	O
which	O
is	O
not	O
of	O
our	O
interest.For	O
example	O
,	O
the	O
protein	O
name	O
Interferon-beta	O
has	O
many	O
spelling	O
variants	O
such	O
as	O
IFN-beta	O
,	O
IFN-B	O
,	O
and	O
beta	O
interferon	O
.	O
Vacuum	O
infiltration	O
has	O
also	O
been	O
used	O
to	O
express	O
an	O
active	O
human	O
beta-interferon	O
in	O
lettuce	O
and	O
to	O
transform	O
lentil	O
cotyledonary	O
nodes	O
and	O
wheat	O
inflorescence	O
tissues	O
14	O
,31	O
,32.2012	O
,	O
which	O
is	O
necessary	O
for	O
the	O
activation	O
of	O
transcription	O
factors	O
that	O
regulate	O
expression	O
of	O
beta	O
interferon	O
and	O
contributes	O
to	O
antiviral	O
immunity	O
.	O
Two	O
recent	O
studies	O
have	O
shown	O
that	O
the	O
equine	O
hepacivirus	O
NS3-4A	O
protease	O
can	O
cleave	O
human	O
MAVS	O
Parera	O
et	O
al	O
.	O
The	O
class	O
Ia	O
genes	O
are	O
surrounded	O
by	O
highly	O
conserved	O
framework	O
genes	O
,	O
which	O
are	O
found	O
in	O
the	O
MHC	O
of	O
all	O
mammals	O
,	O
as	O
well	O
as	O
several	O
antigen	O
processing	O
and	O
transportation	O
genes	O
9.Using	O
interferon-beta	O
,	O
multiple	O
sclerosis	O
and	O
their	O
corresponding	O
synonyms	O
as	O
a	O
query	O
would	O
retrieve	O
articles	O
that	O
used	O
interferon-beta	O
as	O
a	O
treatment	O
,	O
which	O
is	O
not	O
of	O
our	O
interest	O
.	O
UniSen	PROT
and	O
BiSen	PROT
,	O
to	O
support	O
different	O
granularity	O
retrieval	O
See	O
Section	O
2.3.The	O
fine	O
tuning	O
approach	O
differs	O
in	O
the	O
various	O
templates	O
.	O
Therefore	O
leaf	O
vacuum	O
infiltration	O
has	O
been	O
used	O
for	O
expression	O
of	O
β-glucuronidase	O
in	O
Phaseolus	O
vulgaris	O
16	O
and	O
for	O
synthesis	O
of	O
tumor-specific	O
single-chain	O
and	O
chimerical	O
antibodies	O
in	O
tobacco	O
leaves	O
30.To	O
this	O
latter	O
group	O
of	O
genes	O
belong	O
the	O
γ-interferon-inducible	O
proteasome	O
subunit	O
beta	O
type	O
8	O
Psmb8	O
and	O
Psmb9	PROT
,	O
and	O
Tap1	PROT
and	O
Tap2	O
,	O
which	O
are	O
all	O
located	O
in	O
the	O
MHC-II	O
region	O
.	O
Ablation	O
of	O
complexin	O
also	O
increased	O
spontaneous	O
mini	O
release	O
at	O
least	O
in	O
some	O
preparations	O
,	O
suggesting	O
a	O
common	O
mode	O
of	O
action	O
of	O
Syt1	O
or	O
Syt2	O
with	O
complexin	O
in	O
clamping	O
mini	O
release	O
3.Experiments	O
showed	O
that	O
query	O
expansion	O
by	O
via	O
of	O
gene	O
name	O
dictionary	O
could	O
improve	O
recall	O
rate	O
greatly	O
.	O
For	O
example	O
,	O
in	O
the	O
case	O
of	O
topic	O
110	O
,	O
we	O
are	O
interested	O
in	O
the	O
role	O
of	O
interferonbeta	O
gene	O
in	O
Multiple	O
Sclerosis.Several	O
different	O
methods	O
have	O
been	O
used	O
to	O
inoculate	O
Agrobacterium	O
into	O
plants	O
.	O
For	O
example	O
,	O
the	O
protein	O
name	O
Interferon-beta	O
has	O
many	O
spelling	O
variants	O
such	O
as	O
IFN-beta	O
,	O
IFN-B	O
,	O
and	O
beta	O
interferon	O
.	O
TNFa	PROT
,	O
genes	O
coding	O
for	O
several	O
TNF-induced	O
inflammatory	O
mediators	O
,	O
and	O
several	O
interferon	O
induced	O
genes	O
were	O
up-regulated	O
,	O
such	O
as	O
interferon-induced	O
protein	O
with	O
tetratricopeptide	O
repeats	O
1	O
Ifit1	O
,	O
interferon	O
inducible	O
GTPase	O
1	O
Iigp1	O
,	O
Ifit2	PROT
,	O
Irf1	PROT
and	O
Irf7.The	O
50	O
structured	O
topics	O
can	O
be	O
expressed	O
within	O
the	O
biomedical	O
entity	O
tagged	O
,	O
for	O
example	O
,	O
topic110	O
can	O
be	O
expressed	O
as	O
following	O
:	O
Therefore	O
,	O
Interferon-beta	O
and	O
Multiple	O
Sclerosis	O
become	O
the	O
main	O
elements	O
in	O
the	O
query	O
space	O
.	O
For	O
Syt1	O
titration	O
experiments	O
,	O
HEK293T	O
cells	O
were	O
cotransfected	O
as	O
above	O
,	O
except	O
that	O
pCMV5	O
complexin-1	O
was	O
replaced	O
with	O
pCMV5	O
Syt1.Cell	O
lysates	O
were	O
immunoblotted	O
for	O
Syt-1	O
,	O
Cpx1	O
,	O
emerald	O
,	O
SNARE	O
complexes	O
high	O
molecular	O
mass	O
bands	O
,	O
and	O
total	O
SNARE	O
proteins	O
followed	O
by	O
quantitation	O
n	O
=	O
6	O
independent	O
experiments	O
.	O
2012	O
,	O
which	O
is	O
necessary	O
for	O
the	O
activation	O
of	O
transcription	O
factors	O
that	O
regulate	O
expression	O
of	O
beta	O
interferon	O
and	O
contributes	O
to	O
antiviral	O
immunity.HEK293T	O
cells	O
were	O
cotransfected	O
with	O
plasmid	O
expressing	O
Synt-1	O
,	O
SNAP-25	O
,	O
Syb-2	O
,	O
and	O
complexin-1	O
in	O
a	O
1:1:1:3	O
ratio	O
,	O
together	O
with	O
an	O
increasing	O
amount	O
of	O
Syt1	O
expression	O
plasmid	O
0	O
to	O
4-fold	O
,	O
and	O
decreasing	O
amount	O
of	O
emerald	O
expression	O
plasmid	O
GFP	O
;	O
4	O
to	O
0-fold	O
.	O
Syt1	O
increases	O
SNARE	O
complex	O
assembly	O
in	O
presence	O
of	O
complexin-1.Cells	O
were	O
lysed	O
in	O
0.1	O
%	O
Triton	O
X-100	O
containing	O
2	O
mM	O
CaCl2	PROT
,	O
and	O
lysates	O
were	O
immunoblotted	O
for	O
Syt1	O
,	O
Cpx1	O
,	O
emerald	O
,	O
SNARE	O
complexes	O
,	O
and	O
total	O
SNARE	O
proteins	O
A	O
,	O
followed	O
by	O
quantitation	O
using	O
phosphoimager	O
detection	O
B	O
.	O
Moreover	O
,	O
the	O
NS3	O
protein	O
is	O
particularly	O
interesting	O
in	O
terms	O
of	O
host–virus	O
coevolution	O
,	O
as	O
the	O
NS3-4A	O
protease	O
is	O
capable	O
of	O
cleaving	O
human	O
mitochondrial	O
antiviral-signaling	O
protein	O
MAVS	O
Patel	O
et	O
al.Third	O
,	O
immunoprecipitations	O
and	O
pulldowns	O
indicated	O
that	O
Syt1	O
interacts	O
with	O
SNARE	O
proteins	O
not	O
only	O
in	O
a	O
Ca2+-dependent	O
manner	O
but	O
also	O
in	O
a	O
Ca2+-independent	O
manner	O
51–54	O
.	O
A	O
&	O
B.	O
HEK293T	O
cells	O
were	O
cotransfected	O
with	O
plasmid-expressing	O
syntaxin-1a	O
Synt-1	O
,	O
SNAP-25	O
,	O
synaptobrevin-2	O
Syb-2	O
,	O
and	O
complexin-1	O
Cpx1	O
in	O
a	O
constant	O
1:1:1:3	O
ratio	O
,	O
together	O
with	O
an	O
increasing	O
amount	O
of	O
Syt1	O
expression	O
plasmid	O
0	O
to	O
4-fold	O
and	O
a	O
decreasing	O
amount	O
of	O
emerald	O
expression	O
plasmid	O
GFP	O
;	O
4	O
to	O
0-fold	O
to	O
balance	O
the	O
total	O
DNA	O
amount.First	O
,	O
loss-of-function	O
of	O
complexin	O
,	O
which	O
is	O
an	O
essential	O
cofactor	O
of	O
all	O
synaptotagmins	O
in	O
Ca2+	O
triggering	O
of	O
fusion	O
40–44	O
,	O
decreases	O
the	O
size	O
of	O
the	O
RRP	O
approximately	O
2–3-fold	O
45–47	O
.	O
